etilefrine has been researched along with Hyaline Membrane Disease in 1 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanhoe, F | 1 |
1 other study available for etilefrine and Hyaline Membrane Disease
| Article | Year |
|---|---|
Pulmonary vasoconstriction and the pharmacology of respiratory distress (continued).
Topics: Adrenergic Agonists; Catecholamines; Etilefrine; Humans; Hyaline Membrane Disease; Infant, Newborn; | 1966 |